Investment
Features
FeesSafety
Academy
More
Pluang+

Enterprise stablecoin USDGO's circulating supply tops $1 billion, ranking sixth globally among regulated stablecoins.

Market News
20 Jul 2026
Osl Group
View Source
Bullish
pluang ai news

USDGO, an enterprise-grade stablecoin operated by OSL Group, has surpassed a circulating supply of $1 billion, making it the sixth largest regulated stablecoin worldwide and the largest USD-pegged compliant stablecoin from Asia. This rapid growth reflects strong institutional demand in emerging markets and positions USDGO to support large-scale, institutional payments. Backed by high-quality liquid assets and issued by Anchorage Digital Bank, USDGO aims to enhance cross-border payments and treasury management with compliant, efficient on-chain settlement solutions.

More News

Bankruptcy court approves $470M sale of Oceanwide Plaza, paving way for Downtown LA project completion before 2028 Olympics.

Bankruptcy court approves $470M sale of Oceanwide Plaza, paving way for Downtown LA project completion before 2028 Olympics.

The U.S. Bankruptcy Court for the Central District of California confirmed the Plan of Liquidation for Oceanwide Plaza LLC, enabling the $470 million sale of the stalled Downtown Los Angeles development to KPC Square, a joint venture between KPC Grou...

Company Fundamentals
Bullish
1 hour ago
Axsome Therapeutics gets 'Outperform' rating on strong drug pipeline and FDA NDA acceptance for narcolepsy drug.

Axsome Therapeutics gets 'Outperform' rating on strong drug pipeline and FDA NDA acceptance for narcolepsy drug.

Axsome Therapeutics received an "Outperform" rating from BMO Capital due to significant progress in its drug pipeline, including FDA acceptance of its NDA for AXS-12, a narcolepsy treatment with a PDUFA date set for May 1, 2027. The company is also a...

Analyst Insights
Bullish
4 hours ago
Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.

Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.

Novartis is set to report its Q2 earnings with analysts expecting an EPS of $2.17 and revenue of $14.07 billion, following a tough Q1 affected by major patent expirations. Despite revenue challenges, the company maintained strong cash flow of $3.30 b...

Company Fundamentals
Neutral
4 hours ago
Ecopetrol resumes tender offer to acquire 25% of Brava Energia shares on Brazil's B3 exchange

Ecopetrol resumes tender offer to acquire 25% of Brava Energia shares on Brazil's B3 exchange

Ecopetrol's Brazilian subsidiary has resumed a voluntary tender offer to buy 116 million common shares of Brava Energia, representing about 25% of the company. The offer, now updated with regulatory recommendations, will remain open until August 5, 2...

Company Fundamentals
Bullish
4 hours ago
Tanger Inc. shares overvalued by 37%, suggesting a sell due to high consumer risk and priced-in optimism.

Tanger Inc. shares overvalued by 37%, suggesting a sell due to high consumer risk and priced-in optimism.

Tanger Inc., a retail outlet landlord, is currently overvalued with its share price at $41.63 compared to a net asset value per share (NAVPS) of $30.33, indicating a 37% overvaluation. The company's business benefits from low occupancy costs and limi...

Analyst Insights
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App